We have previously reported that administration of a TIR/BB-Loop mimetic AS-1 immediately before reperfusion after ischemia protected the myocardium from I/R injury via suppression of NF-κB binding activity and inflammatory cytosine levels4. This evidence concerns the gene NFKB1 and ischemia.